Panacea Healthcare Solutions Examines the Current and Future of Price Transparency Enforcement in Latest Podcast Episode
CEO Kevin Chmura and Financial Services President Govi Goyal unpack the impact of Trump's executive order and what's next for hospitals
ST. PAUL, Minn., May 28, 2025 /PRNewswire/ -- In the latest episode of Beyond the Bottom Line, Let's Talk Healthcare Finance, Revenue Cycle and Compliance, the official podcast from Panacea Healthcare Solutions, CEO Kevin Chmura sits down once again with Govi Goyal, President of the Financial Services Division, to discuss the far-reaching implications of the executive order signed by President Trump on February 25, 2025. The order, aimed at accelerating enforcement of hospital price transparency, has sparked a wave of CMS compliance actions—and signals much more to come.
In this timely follow-up episode, Chmura and Goyal explore how the order has already led to increased scrutiny of hospitals' machine-readable files (MRFs), with CMS issuing a growing number of violation notices. They also analyze what may be next: expanded reporting requirements, increased update frequency for MRFs, and a broader push for standardization and quality integration.
"It's clear the enforcement environment is shifting fast," said Kevin Chmura, CEO of Panacea Healthcare Solutions. "Hospitals that once viewed price transparency as a back-office requirement now face tangible penalties—and must elevate compliance efforts to meet growing regulatory expectations."
The episode outlines how CMS is currently focused on text file accessibility and website accuracy, with a move toward automated validation and deeper review of the contents of MRFs expected soon. Even minor missteps—such as using the word "pricing" instead of "price" in a footer—have triggered official notices.
Goyal, a nationally recognized expert in price transparency strategy, shared both strategic insight and practical guidance for hospitals.
"We're seeing a phased enforcement approach, and hospitals need to be ready for what's coming next," said Govi Goyal, President of Panacea's Financial Services Division. "That means reviewing your text file, running your MRF through the CMS validator, and making sure your patient estimation system aligns with your posted rates. Don't wait for the letter—proactively address compliance gaps now."
Beyond enforcement, the discussion highlights the broader implications of the executive order. With commercial payers required to update their pricing files monthly, Goyal suggests that hospitals could soon face similar update frequencies. The episode also explores potential legislative moves to expand transparency requirements to non-hospital providers and incorporate quality data into pricing disclosures.
This episode is essential listening for compliance professionals, CFOs, revenue integrity leaders, and legal teams seeking to stay ahead of federal price transparency enforcement and regulatory change.
Listen to the Podcast
To hear the full conversation and learn what actions your organization should take now, visit:Listen Now on Panacea's Website. Also available on Apple Podcasts
About Panacea Healthcare SolutionsPanacea Healthcare Solutions provides strategic, innovative, and compliant financial, revenue integrity, and pricing solutions to healthcare organizations nationwide. From chargemaster and price transparency tools to financial strategy and compliance services, Panacea empowers providers to optimize performance and stay ahead of regulatory change.
View original content to download multimedia:https://www.prnewswire.com/news-releases/panacea-healthcare-solutions-examines-the-current-and-future-of-price-transparency-enforcement-in-latest-podcast-episode-302462338.html
SOURCE Panacea Healthcare Solutions
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
TD SYNNEX (SNX) Reports Q2: Everything You Need To Know Ahead Of Earnings
IT distribution giant TD SYNNEX (NYSE:SNX) will be reporting results this Tuesday before market hours. Here's what to look for. TD SYNNEX missed analysts' revenue expectations by 1.7% last quarter, reporting revenues of $14.53 billion, up 4% year on year. It was a softer quarter for the company, with a significant miss of analysts' EPS estimates. Is TD SYNNEX a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting TD SYNNEX's revenue to grow 2.6% year on year to $14.32 billion, improving from its flat revenue in the same quarter last year. Adjusted earnings are expected to come in at $2.75 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. TD SYNNEX has missed Wall Street's revenue estimates five times over the last two years. Looking at TD SYNNEX's peers in the tech hardware & electronics segment, only Jabil has reported results so far. It beat analysts' revenue estimates by 11.2%, delivering year-on-year sales growth of 15.7%. The stock traded up 13.1% on the results. Read our full analysis of Jabil's earnings results here. Investors in the tech hardware & electronics segment have had fairly steady hands going into earnings, with share prices down 1.4% on average over the last month. TD SYNNEX's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $135.99 (compared to the current share price of $125.18). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Carnival Earnings: What To Look For From CCL
Cruise ship company Carnival (NYSE:CCL) will be announcing earnings results this Tuesday before market open. Here's what to look for. Carnival beat analysts' revenue expectations by 0.9% last quarter, reporting revenues of $5.81 billion, up 7.5% year on year. It was a strong quarter for the company, with a solid beat of analysts' EPS estimates and an impressive beat of analysts' adjusted operating income estimates. It reported 24.3 million passenger cruise days, up 3.4% year on year. Is Carnival a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Carnival's revenue to grow 7.6% year on year to $6.22 billion, slowing from the 17.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.24 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Carnival has missed Wall Street's revenue estimates three times over the last two years. With Carnival being the first among its peers to report earnings this season, we don't have anywhere else to look to get a hint at how this quarter will unravel for consumer discretionary stocks. However, investors in the segment have had steady hands going into earnings, with share prices flat over the last month. Carnival's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $28.55 (compared to the current share price of $23.82). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
3 hours ago
- Yahoo
Carnival Earnings: What To Look For From CCL
Cruise ship company Carnival (NYSE:CCL) will be announcing earnings results this Tuesday before market open. Here's what to look for. Carnival beat analysts' revenue expectations by 0.9% last quarter, reporting revenues of $5.81 billion, up 7.5% year on year. It was a strong quarter for the company, with a solid beat of analysts' EPS estimates and an impressive beat of analysts' adjusted operating income estimates. It reported 24.3 million passenger cruise days, up 3.4% year on year. Is Carnival a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Carnival's revenue to grow 7.6% year on year to $6.22 billion, slowing from the 17.7% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.24 per share. Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Carnival has missed Wall Street's revenue estimates three times over the last two years. With Carnival being the first among its peers to report earnings this season, we don't have anywhere else to look to get a hint at how this quarter will unravel for consumer discretionary stocks. However, investors in the segment have had steady hands going into earnings, with share prices flat over the last month. Carnival's stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $28.55 (compared to the current share price of $23.82). Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
